Furthermore, Dan et al. assessed the AKT/glycogen synthase kinase-3 beta (GSK3β)/β-catenin signaling pathway in AML for the effects of nicotinamide phosphoribosyltransferase (NAMPT) and SIRT2, which showed high expression in blasts. This evidence concerns the gene GSK3B and acute myeloid leukemia.